✦ LIBER ✦

Epirubicin as a single agent therapy for the treatment of breast cancer — A pharmacokinetic and clinical study

✍ Scribed by Staffan Eksborg; Lennart Hardell; Nils-Olof Bengtsson; Marie Sjödin; Birgitta Elfsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I clinical and pharmacokinetic s

✍ Chan, S.; Campone, M.; Santoro, A.; Conte, P. F.; Bostnavaron, M.; Nguyen, L. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 192 KB

P86 Epirubicin as a single agent in comp

✍ M. Colozza; G. Bisagni; A.M. Mosconi; S. Gori; C. Boni; A. Rosa Bian; R. Sabbati 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Epirubicin versus CMF as adjuvant therap

✍ M Colozza; G Bisagni; A.M Mosconi; S Gori; C Boni; R Sabbatini; A Frassoldati; R 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 191 KB

A pilot study of quinidine and epirubici

✍ Jones, RD; Kerr, DJ; Harnett, AN; Rankin, EM; Ray, S; Kaye, SB 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 493 KB

Mitoxantrone for the treatment of advanc

✍ Cornbleet, Michael A; Stuart-Harris, Robin C; Smith, Ian E; Coleman, Robert E; R 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 639 KB

Combined epirubicin and vinorelbine as f

✍ B Ejlertsen; I Højris; S Hansen; K Møholt; B Kristensen; H.T Mouridsen; J Anders 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB